- Home
- BHST vs SVII Comparison
BHST vs SVII Comparison
Compare BHST & SVII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHST
- SVII
- Stock Information
- Founded
- BHST 2007
- SVII 2021
- Country
- BHST Canada
- SVII United States
- Employees
- BHST N/A
- SVII N/A
- Industry
- BHST
- SVII Blank Checks
- Sector
- BHST
- SVII Finance
- Exchange
- BHST Nasdaq
- SVII Nasdaq
- Market Cap
- BHST 106.0M
- SVII 116.6M
- IPO Year
- BHST N/A
- SVII 2022
- Fundamental
- Price
- BHST $7.06
- SVII $11.71
- Analyst Decision
- BHST Strong Buy
- SVII
- Analyst Count
- BHST 2
- SVII 0
- Target Price
- BHST $13.00
- SVII N/A
- AVG Volume (30 Days)
- BHST 11.9K
- SVII 13.7K
- Earning Date
- BHST 08-15-2025
- SVII 01-01-0001
- Dividend Yield
- BHST N/A
- SVII N/A
- EPS Growth
- BHST N/A
- SVII N/A
- EPS
- BHST N/A
- SVII 0.25
- Revenue
- BHST $27,704,000.00
- SVII N/A
- Revenue This Year
- BHST $116.40
- SVII N/A
- Revenue Next Year
- BHST $55.91
- SVII N/A
- P/E Ratio
- BHST N/A
- SVII $47.09
- Revenue Growth
- BHST 74.76
- SVII N/A
- 52 Week Low
- BHST $4.66
- SVII $11.06
- 52 Week High
- BHST $7.86
- SVII $11.90
- Technical
- Relative Strength Index (RSI)
- BHST N/A
- SVII 50.67
- Support Level
- BHST N/A
- SVII $11.65
- Resistance Level
- BHST N/A
- SVII $11.78
- Average True Range (ATR)
- BHST 0.00
- SVII 0.07
- MACD
- BHST 0.00
- SVII -0.01
- Stochastic Oscillator
- BHST 0.00
- SVII 25.53
About BHST BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
About SVII Spring Valley Acquisition Corp. II
Spring Valley Acquisition Corp II is a blank check company.